We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Sensor Detects Antibodies to Gliadin, a Component of Gluten

By LabMedica International staff writers
Posted on 19 Nov 2008
Scientists in Spain and the United Kingdom have developed a fast test for identifying the food protein that triggers celiac disease, a difficult-to-diagnose digestive disease involving the inability to digest a protein called gluten that is present in wheat, oats, rye, and barley. More...
They have developed an electrochemical immunosensor that detects antibodies to the protein gliadin, which is a component of gluten.

The standard test for gliadin is an enzyme-linked immunosorbant assay (ELISA). The test using the new immunosensor took barely 90 minutes to detect gliadin in the parts per billion range compared to eight hours for the ELISA. Both tests were equally accurate but the new sensor would be easier to use at food manufacturing plants, the scientists note.

Avoiding food that contains gluten can be difficult for patients with celiac disease because gluten may be a hidden ingredient in unsuspected foods, such as soy sauce, canned soups, and licorice candy. Some prepared foods list gluten content on package labels, but identifying its presence is difficult and time-consuming.

The sensor could help millions of people avoid diarrhea, bloating, and other symptoms that occur when they unknowingly eat foods containing gluten.

The study was performed by Alex Fragoso, Ph.D. and Ciara O'Sullivan from the Universitat Rovirai I Virgili (Tarragona, Spain) and Kings College London (U.K), together with colleagues in Spain. It appeared in the online edition of Analytical Chemistry (American Society of Chemistry) on October 29, 2008.

Related Links:
Universitat Rovirai I Virgili
Kings College London


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: LiDia-SEQ aims to deliver near-patient NGS testing capabilities to hospitals, labs and clinics (Photo courtesy of DNAe)

World's First NGS-Based Diagnostic Platform Fully Automates Sample-To-Result Process Within Single Device

Rapid point-of-need diagnostics are of critical need, especially in the areas of infectious disease and cancer testing and monitoring. Now, a direct-from-specimen platform that performs genomic analysis... Read more

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: The AI tool advances precision diagnostics by linking genetic mutations directly to disease types (Photo courtesy of Shutterstock)

AI Tool Simultaneously Identifies Genetic Mutations and Disease Type

Interpreting genetic test results remains a major challenge in modern medicine, particularly for rare and complex diseases. While existing tools can indicate whether a genetic mutation is harmful, they... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.